https://www.kadcyla.com/patient/early-breast-cancer.html
I’ll leave this here for any HER2 positive early breast cancer patients who may be checking BCNA . Using kadcyla/ T-DMI chemo in early breast cancer is a fairly new treatment regime for cases where there hasn’t been complete pathological response to adjuvant chemo. Trials with early breast cancer HER2 positive patients (KATHLEEN study) have been very promising . I found a lady this weekend at our breast cancer support group , same as me EBC, HER2 positive with partial path response , (not complete) who’s been on this regime and she was saying it was easier than AC chemo for her, and side effects so,far have been ok/manageable. I’ll be seeing my oncologist soon and as long as we have a strategy for side effects ( eg I already have numb toes from other chemo, so am concerned if it worsens ) I’m going to take her advice and proceed with T-DMI .
